New Method for Real-time Detection of Tissue Ischemia (ISCALERT)

New Method for Real-time Detection of Tissue Ischemia; IscAlert™ - Study

This is a prospective, single arm, open, single centre clinical investigation designed to examine the feasibility and safety of the IscAlert™ device in patients scheduled for limb (arm/leg) surgery with tourniquet. IscAlert is measuring carbon dioxide in muscular and subcutaneous tissue. IscAlert is inserted into normal muscle and subcutaneous tissue in ischemic (operated limb with a tourniquet) and non-ischemic limb (non-operated limb).After the tourniquet is inflated, ischemia develops in the muscles and subcutaneous tissue. This will result in an increase in carbon dioxide, which will be detected by the sensor on the operated extremity, while the sensor on the non-operated will show normal values. After releasing the tourniquet cuff, the muscle will be reperfused and the carbon dioxide level is expected to decrease into normal levels. 50 number of patients will be enrolled to undergo the procedures. The IscAlert will be removed from the patient before the patient is discharged from the operating room, but in 25 of the patients, IscAlert™ will be inserted for 72 hours in the operated extremity after the end of surgery. After this, the sensors are removed.250 Devices is planned to be used in this clinical study.

Study Overview

• Status: Withdrawn
• Conditions: Ischemia; Carbon Dioxide; Blood Circulation Disorder; Biosensing Techniques
• Intervention / Treatment: Device: IscAlert

Detailed Description

This is a prospective, single arm, open, single centre clinical investigation designed to examine the feasibility and safety of the IscAlert™ device in patients scheduled for limb (arm/leg) surgery with tourniquet.

50 number of patients will be enrolled to undergo the procedures detailed in this clinical investigational plan using 250 devices.

IscAlert is 0.8 mm in diameter and in vitro testing, shows stable and accurate measurements of tissue carbon dioxide . More than 100 animal experiments have been done with the sensor. The experiments have shown that the sensor detects ischemia (Increased carbon dioxide-measurements) in real time in the following organs and tissues: Brain, heart, liver, kidneys, pancreas, intestines, musculature and subcutaneous tissue. Sensitivity and specificity are close to 100%. The sensors are inserted into tissue by a split needle technique. The split needle is the size of a 3-gauge peripheral venous catheter. In animal studies, no complications have been detected when using the sensor.

The IscAlert catheters are connected to an electronics unit that is fixed to the skin with an adhesive plaster outside the sterile area. The electrical signals are redirected to a personal computer approved for clinical use which continuously records tissue pressures of carbon dioxide .

IscAlert is inserted into normal muscle and subcutaneous tissue proximal on the limb to be operated. The insertion is distal to the blood cuff, and far away from the surgery field. The insertion is done under sterile conditions in accordance with standard sterility criteria at the hospital. No pain during insertion will occur because of insertion is performed after anesthesia induction. Also, the insertion can be compared to an intramuscular injection.

An identical IscAlert catheter is also inserted in the opposite extremity that is not to be operated and serves as a reference value. After the tourniquet is inflated, ischemia develops in the muscles and subcutaneous tissue. This will result in an increase in carbon dioxide, which will be detected by the sensor on the operated extremity, while the sensor on the non-operated will show normal values.

After releasing the tourniquet cuff, the muscle will be reperfused and the carbon dioxide level is expected to decrease into normal levels within 15 - 45 minutes. In 25 patients, the biosensors will be removed from the patient before the patient is discharged from the operating room, but in 25 of the patients, IscAlert will be inserted for 72 hours in the operated extremity after the end of surgery to identify drifting of the sensors. After this, the sensors are removed.

The primary objective is to evaluate the ability of the IscAlert device to measure carbon dioxide levels in ischemic and non-ischemic limb musculature and subcutaneous tissue in patients who experience orthopedic surgery with limb tourniquet and to assess the safety/efficacy using device IscAlert.

Our hypotheses are:

1. The IscAlert device will be able to detect the presence of ischemia in muscle and subcutaneous tissue, whereby carbon dioxide levels, measured by IscAlert, will be higher in ischemic musculature than non-ischemic musculature in patients undergoing orthopedic limb surgery.
2. No clinically significant bleeding or infection will occur using IscAlert in this clinical study.

• Study Type: Observational

Contacts and Locations

Study Locations

• Norway
  • Oslo, Norway, 0424
    • Oslo University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients who need limb surgery with tourniquet cuff

Description

Inclusion Criteria:

• Patients must be scheduled for orthopedic limb surgery with planned use of tourniquet.
• Subject must be ≥ 18 years
• Able to give written signed informed consent
• Tourniquet planned to be used > 30 minutes

Exclusion Criteria:

• Sign of inflammation/infection, hematoma, and traumatized tissue at insertion site
• Chronic use of anticoagulants

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Group 1; Patients scheduled for limb (arm/leg) surgery with tourniquet where IscAlert is removed immediately after surgery. All patients will receive 3 sensors in the limb undergoing surgery and two control sensors in the opposite limb. The sensor in the opposite extremity which is not to be operated serves as a reference value for carbon dioxide.	Device: IscAlert; 3 IscAlert sensors in the limb undergoing surgery and two control sensors in the opposite limb are inserted and carbon dioxide is measured continuously.
Group 2; Patients scheduled for limb (arm/leg) surgery with tourniquet where IscAlert is removed 72 hours after surgery. All patients will receive 3 sensors in the limb undergoing surgery and two control sensors in the opposite limb. The sensor in the opposite extremity which is not to be operated serves as a reference value for carbon dioxide.	Device: IscAlert; 3 IscAlert sensors in the limb undergoing surgery and two control sensors in the opposite limb are inserted and carbon dioxide is measured continuously.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Tissue carbon dioxide level	Tissue carbon dioxide level (kPa) during insertion period	72 hours

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Bleeding	Amount of blood from insertion site (ml)	72 hours
Infection	Infection from insertion site at the discretion of the investigator (yes or no)	1 week
Arterial carbon dioxide level	Blood gass analysis of carbon dioxide during surgery (kPa)	2 hours
Arterial lactate level	Blood gass analysis of lactate during surgery (mmol/L)	2 hours
Arterial pH level	Blood gass analysis of pH during surgery	2 hours
Arterial Oxygen level	Blood gass analysis of Oxygen during surgery (Kpa)	2 hours
Time of tourniquet	Minutes of inflated tourniquet during surgery (minutes)	2 hours
End-tidal level of carbon dioxide	End-tidal level of carbon dioxide during anesthesia (kPa)	2 hours

Collaborators and Investigators

• Sponsor: Oslo University Hospital
• Collaborators: European Commission
• Investigators: Principal Investigator: Magne Røkkum, MD, Ph.D, Oslo University Hospital

Study record dates

Study Major Dates

• Study Start (Anticipated): May 14, 2021
• Primary Completion (Actual): May 14, 2021
• Study Completion (Actual): May 14, 2021

Study Registration Dates

• First Submitted: August 10, 2020
• First Submitted That Met QC Criteria: May 14, 2021
• First Posted (Actual): May 19, 2021

Study Record Updates

• Last Update Posted (Actual): May 24, 2021
• Last Update Submitted That Met QC Criteria: May 19, 2021
• Last Verified: May 1, 2021

More Information

Terms related to this study

• Keywords: Surgery; Subcutaneous; Ischemia; Carbon dioxide; Biosensor; Orthopedic; Limb; Musculature
• Additional Relevant MeSH Terms: Pathologic Processes; Ischemia
• Other Study ID Numbers: 1-20

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: No plan to share IPD to other researchers

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No